FDA cancels pivotal advisory meeting about next season's flu vaccine
An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the ...
FDA cancels meeting to select flu strains for next season's shots
A Food and Drug Administration vaccine advisory committee meeting scheduled for March to select the strains to be included in ...
FDA meeting to choose flu vaccine composition canceled without explanation
A March meeting of outside advisers to the United States Food and Drug Administration to discuss the composition of flu ...
Boise State Public Radio10h
The FDA has canceled an important upcoming meeting about vaccines
The FDA's Vaccines and Related Biological Products Advisory Committee was scheduled for next month. But the agency notified committee members that the meeting had been canceled.
FDA Drags Heels on Vaccine Plans
The Department of Health and Human Services told Newsweek that it is "necessary to review agreements for vaccine production." ...
FDA cancels meeting to choose flu strains for next year's vaccine
The Food and Drug Administration Wednesday abruptly and unexpectedly cancelled a planned March 13 vaccine advisory committee ...
FDA says Ozempic shortage is over, chilling boom in off-brand versions
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
cidrap.umn14h
FDA cancels advisory committee meeting on flu vaccine strain selection
VRBPAC members were alerted that the meeting was canceled in an email from the FDA that did not include an explanation, ...
Abortion pill maker enters legal battle over FDA rules
The country’s only manufacturer of generic abortion medication asked to be a part of the first legal fight over the procedure ...
FDA and USDA among federal agencies aiming to rehire workers hit by mass firings
A number of agencies are looking to rehire federal workers who lost their jobs as part of the Trump administration's mission ...
Yahoo Finance4d
United States FDA Approves NM8074 (Ruxoprubart) IND for Treating Dermatomyositis (DM): A Chronic Inflammatory Disorder of the Skin
The United States FDA Approves the Initiation for Phase II Efficacy Trial in Dermatomyositis (DM) Patients: A Skin & Muscle Disorder CLEVELAND, Feb. 24, 2025 (GLOBE NEWSWIRE) -- NovelMed ...